Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Aug 31, 2025 | (FY)May 31, 2025 | (Q4)May 31, 2025 | (Q3)Feb 28, 2025 | (Q2)Nov 30, 2024 | (Q1)Aug 31, 2024 | (FY)May 31, 2024 | (Q4)May 31, 2024 | (Q3)Feb 29, 2024 | (Q2)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 11.91%131.77M | 28.46%473.28M | 27.63%119.66M | 30.35%114.3M | 30.71%121.57M | 25.28%117.75M | 35.82%368.44M | 3.63%93.76M | 7.54%87.69M | 17.09%93M |
| Cost of revenue | 28.40%431.26M | 48.53%335.88M | ||||||||
| Gross profit | 29.06%42.02M | -27.84%32.56M | ||||||||
| Operating expense | 12.09%33.19M | 38.95%29.61M | ||||||||
| Selling and administrative expenses | ---- | 12.09%33.19M | ---- | ---- | ---- | ---- | 38.95%29.61M | ---- | ---- | ---- |
| -Selling and marketing expense | ---- | -17.69%921.63K | ---- | ---- | ---- | ---- | 41.48%1.12M | ---- | ---- | ---- |
| -General and administrative expense | ---- | 13.26%32.27M | ---- | ---- | ---- | ---- | 38.86%28.49M | ---- | ---- | ---- |
| Operating profit | 62.33%8.58M | 199.40%8.84M | 198.21%8.58M | 17.59%3.78M | -67.74%3.43M | 8.79%5.29M | -87.61%2.95M | -327.81%-8.74M | -55.75%3.22M | 97.05%10.62M |
| Net non-operating interest income (expenses) | -13.83%-1.66M | -34.62%-1.46M | ||||||||
| Non-operating interest income | 3.30%487.63K | 11.71%1.95M | -10.72%507.07K | -1.84%477.43K | 10.38%497.87K | 93.39%472.05K | --1.75M | --567.93K | 144.12%486.38K | 339.25%451.07K |
| Non-operating interest expense | 7.84%420.38K | 13.83%1.66M | 13.26%478.73K | 14.09%387.58K | 15.75%408.67K | 12.31%389.82K | 34.62%1.46M | -24.54%422.69K | -0.39%339.7K | 95.00%353.05K |
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 30.57%-2.63M | -41,907.33%-3.78M | ||||||||
| Less:Write off | ---- | -30.57%2.63M | ---- | ---- | ---- | ---- | 41,907.33%3.78M | ---- | ---- | ---- |
| Other non-operating income (expenses) | 66.08%6.49M | 94.31%3.91M | ||||||||
| Income before tax | 93.53%5.89M | 583.07%11.04M | 147.75%5.37M | 2.21%1.43M | -86.32%1.19M | 8.73%3.04M | -93.47%1.62M | -235.61%-11.26M | -75.54%1.4M | 127.55%8.67M |
| Income tax | 134.79%1.71M | 349.01%4.59M | 379.48%3.26M | -40.59%373.12K | -77.28%225.76K | 28.32%730.43K | -46.61%1.02M | 53.27%-1.17M | -33.91%628K | -37.12%993.88K |
| Net income | 80.50%4.17M | 987.15%6.44M | 120.92%2.11M | 36.96%1.06M | -87.49%960.14K | 3.73%2.31M | -97.40%592.6K | -193.41%-10.09M | -83.81%773.53K | 244.27%7.68M |
| Net income continuous operations | 80.50%4.17M | 987.15%6.44M | 120.92%2.11M | 36.96%1.06M | -87.49%960.14K | 3.73%2.31M | -97.40%592.6K | -193.41%-10.09M | -83.81%773.53K | 244.27%7.68M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to the company | 80.50%4.17M | 987.15%6.44M | 120.92%2.11M | 36.96%1.06M | -87.49%960.14K | 3.73%2.31M | -97.40%592.6K | -193.41%-10.09M | -83.81%773.53K | 244.27%7.68M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 80.50%4.17M | 987.15%6.44M | 120.92%2.11M | 36.96%1.06M | -87.49%960.14K | 3.73%2.31M | -97.40%592.6K | -193.41%-10.09M | -83.81%773.53K | 244.27%7.68M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 73.53%0.0059 | 830.00%0.0093 | 119.87%0.003 | 25.00%0.0015 | -87.83%0.0014 | -17.07%0.0034 | -97.71%0.001 | -172.25%-0.0151 | -86.67%0.0012 | 173.81%0.0115 |
| Diluted earnings per share | 73.53%0.0059 | 933.33%0.0093 | 119.87%0.003 | 25.00%0.0015 | -87.83%0.0014 | -17.07%0.0034 | -97.87%0.0009 | -177.04%-0.0151 | -86.67%0.0012 | 173.81%0.0115 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0.005 | 0.005 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.